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Endogenous betaretroviruses (enJSRVs) of sheep are expressed abundantly in the female reproductive tract
and play a crucial role in conceptus development and placental morphogenesis. Interestingly, the colonization
of the sheep genome by enJSRVs is likely still ongoing. During early pregnancy, enJSRV expression correlates
with the production of tau interferon (IFNT), a type I IFN, by the developing conceptus. IFNT is the pregnancy
recognition signal in ruminants and possesses potent antiviral activity. In this study, we show that IFNT
induces the expression of bone marrow stromal cell antigen 2 (BST2) (also termed CD317/tetherin) both in
vitro and in vivo. The BST2 gene is duplicated in ruminants. Transfection assays found that ovine BST2 proteins
(oBST2A and oBST2B) block release of viral particles produced by intact enJSRV loci and of related exogenous
and pathogenic jaagsiekte sheep retrovirus (JSRV). Ovine BST2A appears to restrict enJSRVs more efficiently
than oBST2B. In vivo, the expression of BST2A/B and enJSRVs in the endometrium increases after day 12 and
remains high between days 14 and 20 of pregnancy. In situ hybridization analyses found that oBST2A is
expressed mainly in the endometrial stromal cells but not in the luminal and glandular epithelial cells, in
which enJSRVs are highly expressed. In conclusion, enJSRVs may have coevolved in the presence of oBST2A/B
by being expressed in different cellular compartments of the same organ. Viral expression in cells unable to
express BST2 may be one of the mechanisms used by retroviruses to escape restriction.
One of the steps of the retrovirus replication cycle is the
integration of the reverse-transcribed genome (“provirus”)
into the host cell genome. During evolution, retroviruses have
infected the germ line of their host, leading to stably integrated
“endogenous” retroviruses (ERVs) that are transmitted verti-
cally from generation to generation in a Mendelian fashion.
Most ERVs have accumulated mutations, substitutions, or de-
letions that render them defective in establishing a complete
viral replication cycle. However, recently integrated ERVs,
such as some of the koala and sheep ERVs, possess an intact
genomic structure (1, 3, 52). In addition, some of the more
ancient ERV loci have maintained genes with open reading
frames (ORFs) intact millions of years after their integration in
the host genome. This is believed to be the result, in some
cases, of positive selection operated by the host because of the
beneficial effect afforded by some ERVs. The development of
the placenta is one of the best examples offered by the symbi-
otic relationship between ERVs and their hosts (11, 12).
The sheep genome contains at least 27 copies of endogenous
betaretroviruses (enJSRVs) highly related to the exogenous
and pathogenic jaagsiekte sheep retrovirus (JSRV) (1, 3, 6, 7,
57). Some of the enJSRV loci are insertionally polymorphic
within the sheep population, possess an intact genomic struc-
ture with uninterrupted ORFs, and therefore are potentially
replication competent (1). The data obtained so far support
the idea of an ongoing invasion of the sheep genome by
enJSRVs. Some of the biological properties of enJSRVs are
vital for their host. Indeed, enJSRV envelope protein (Env)
expression is necessary for conceptus (embryo and associated
extraembryonic membrane) development and placental mor-
phogenesis and thus mandatory for pregnancy (11, 12). More-
over, some enJSRVs are able to block, at least in vitro, several
steps of the replication cycle of the exogenous and pathogenic
JSRV (1, 2, 29, 30, 47).
Interestingly, enJSRVs are expressed abundantly in the fe-
male reproductive tract of sheep, particularly in the endome-
trium of the uterus (36). The peak of enJSRV expression in the
endometrium during early pregnancy coincides with the onset
and peak expression of a type I interferon (tau interferon
[IFNT]) that functions as the pregnancy recognition signal
released from the developing conceptus (43, 46, 48). IFNT has
potent antiviral activity both in vitro and in vivo against a
variety of viruses because it induces the same antiviral path-
ways as other type I IFNs (22, 41, 53). Interestingly, ovine bone
marrow stromal cell antigen 2 (BST2)/CD317/tetherin is up-
regulated by IFNT (8, 17). BST2 has potent antiviral activity
(33, 54) and is a type II membrane protein consisting of an
N-terminal cytoplasmic tail, a transmembrane domain fol-
lowed by an extracellular one important for dimerization, and
a glycosylphosphatidylinositol (GPI)-linked lipid anchor essen-
tial for the viral restriction activity (24, 34). Human BST2
(termed hBST2 in this study and also known as CD317 or
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tetherin) restricts HIV-1 viral particle release in the absence of
one of its accessory proteins, Vpu (33, 54). In the presence of
BST2 and in the absence of Vpu, nascent HIV-1 virions are
retained or “tethered” at the cell surface and subsequently
endocytosed (40). However, in the presence of Vpu, restriction
by hBST2 is overcome, and HIV-1 particle release is rescued
(33, 54). Human BST2 has a broad antiviral spectrum, and
several studies found that this protein blocks the viral particle
release of many enveloped viruses, including several retrovi-
ruses, filoviruses, and arenaviruses (21, 23, 27, 42). In turn,
different viruses have evolved a variety of countermeasures to
overcome the block induced by BST2 (18, 20, 21, 23, 25, 27, 32,
33, 58).
During early pregnancy, expression of enJSRVs in the endo-
metrium and production of IFNT by the conceptus are corre-
lated. This observation raises the question of how enJSRVs
and the IFNT-inducible gene BST2 have coevolved. In this
study, we found that IFNT induces expression of oBST2/teth-
erin both in vitro and in vivo. The BST2 gene is duplicated in
sheep, and both oBST2A and oBST2B block viral particle
release of JSRV and of an intact enJSRV provirus, enJSRV-
18. Further, we found that oBST2A is expressed mainly in the
stromal cells of the endometrium during early pregnancy but
not in the endometrial luminal and glandular epithelial cells
that express abundant levels of enJSRVs.
MATERIALS AND METHODS
Plasmids. Plasmids pCMV4JS21 and pCMV5enJS-18 expressing the full-
length JSRV21 molecular clone and the endogenous provirus enJSRV-18, re-
spectively, have been described (1, 39). The expression plasmids for hBST-2/
tetherin tagged with the hemagglutinin (HA) epitope and for an HIV-1 clone
deleted of Vpu (HIV-1 Vpu) were also described previously (28, 32). Full-
length oBST2A cDNA was amplified by reverse transcription (RT)-PCR using
total RNA isolated from the endometrium of a day 18 pregnant ewe with a sense
primer (5-GGT CGG CAC CAC TAT TAT GC-3) and antisense primer
(5-AGT CAG GAA GCC TCA CAC AGG-3). The ovine BST2B gene was first
partially amplified from sheep genomic DNA by PCR with a sense primer
(5-GGA GCT TGT CAT TGG TCG GCA CC-3) and antisense primer (5-
TCA TTT CTT CAG ACA CTT GCA GAT GAT G-3). Subsequently, in order
to confirm its 3-end sequence, a partial oBST2B cDNA was amplified by RT-
PCR from total RNA isolated from sheep choroid plexus cells treated with
IFNT. oBST2A and -2B cDNAs were cloned into pCI, with or without an HA
epitope tag, resulting in plasmids pCIoBST2A, pCIoBST2B, and pCIoBST2A-
HA. The HA tags were inserted into the oBST2A and -2B proteins after amino
acid residues 135 and 146, respectively, analogously to the HA-tagged version of
hBST2/tetherin, as described previously (28).
Cell cultures, transfections, and viral preparations. Human 293T cells and
sheep CPT-Tert cells were cultured in Dulbecco’s modified Eagle medium or
Iscove’s modified Dulbecco’s medium, respectively, supplemented with 10% fetal
bovine serum at 37°C, 5% CO2, and 95% humidity. CPT-Tert derives from sheep
choroid plexus cells immortalized with the simian virus 40 (SV40) T antigen and
human telomerase reverse transcriptase (hTERT). For Western blot analysis,
viruses were produced by transient transfection of 293T or CPT-Tert cells using
the Calphos mammalian transfection kit (Clontech) or Lipofectamine 2000 (In-
vitrogen), respectively, according to the manufacturer’s instructions. Viral par-
ticle release assays were performed with 293T cells cultured in petri dishes
(10-cm diameter) transfected with 2, 4, and 1 g of the expression plasmids of
HIV-1 Vpu, JSRV, and enJSRV-18, respectively, either alone or with increas-
ing amounts (0.1 to 1 g) of the expression plasmids for oBST2A, oBST2B (with
or without HA tags), or hBST2 with an HA tag. The amounts of plasmid DNA
transfected were the same in each transfection (the empty pCI vector was used
to balance each transfection). Viral particle release assays were performed with
CPT-Tert cells transfected with 4 g of the enJSRV-18 expression plasmid and
increasing amounts of oBST2A and -2B expression plasmids (0.4 to 4 g) in
order to maintain the ratio of expression plasmids for enJSRV and oBST2 used
in the experiments performed with 293T cells. In each transfection, 1 g
pEGFP-C1 (Clontech) was used as a control for transfection efficiency. Cell
supernatants were collected at 24 h posttransfection, and viral particles were
concentrated by ultracentrifugation. For analysis of intracellular proteins, cells
were lysed by standard techniques as described previously (56).
RT-PCR. Expression of oBST2A and oBST2B in CPT-Tert in the presence of
carrier or 10,000 antiviral units (AVU) of IFNT for 24 h was tested by RT-PCR.
Total RNA was isolated from CPT-Tert using the Paris kit (Ambion) as recom-
mended by the manufacturers. oBST2A was amplified by RT-PCR using the
SuperScript III kit (Invitrogen) and sense primer 5-ATG ATG GAC AAA TTG
GAA GGA TCT-3 and antisense primer 5-AAG ACC GCG ATC ACA ACG
AAT-3, while oBST2B was amplified using the sense primer 5-GTT CCT GAT
GCC CAT AGA CGA AGA AGA G-3 and antisense primer 5-CGA GTC
GTC ACC ACA CCC CCG AAA AAG GA-3. As an RNA quality control,
succinate dehydrogenase (SDHA) cDNA was amplified as described previously
(31).
Phylogenetic analysis. Phylogenetic analysis of BST2 proteins from different
species was performed using ClustalX, and a phylogenetic tree was built based on
the neighbor-joining method, in which the evolutionary rates of the different
lineages are free to differ. Clade support was evaluated based on 1,000 bootstrap
replicates using the same algorithm.
Western blotting. SDS-PAGE and Western blot analyses were performed with
concentrated viral particles and cell lysates (250 g of protein extracts) as
previously described (39, 56). Gag proteins were detected with a rabbit poly-
clonal serum against the JSRV major capsid protein (CA) or monoclonal anti-
bodies toward HIV-1 p55/p24 (15, 30). The human and ovine BST2 proteins
tagged with HA were detected with mouse monoclonal anti-HA antibodies
(Covance). The enhanced green fluorescent proteins (eGFP) were revealed
using a rabbit polyclonal antibody directed against GFP (ab290; Abcam). Mem-
branes were exposed to the appropriate peroxidase-conjugated secondary anti-
bodies and further developed by chemiluminescence using ECL Plus (Amer-
sham). Western blots were quantified by scanning membranes and measuring
chemifluorescence in a Molecular Dynamics Storm 840 imaging system using
ImageQuant TL software (Molecular Dynamics). Each experiment (from trans-
fection to Western blotting) was performed independently at least three times.
Animal studies. All experimental and surgical procedures were in compliance
with the Guide for the Care and Use of Agriculture Animals in Research and
Teaching and approved by the Institutional Animal Care and Use Committee of
Texas A&M University.
Study 1. At estrus (day 0), ewes were mated to either an intact or vasectomized
ram and then hysterectomized (n  5 ewes/day) on days 3, 6, 10, 12, 14, 16, 18,
and 20 of the estrous cycle or pregnancy. At hysterectomy, several sections (0.5
cm) from the mid-portion of each uterine horn ipsilateral to the corpus luteum
(CL) were fixed in fresh 4% paraformaldehyde in phosphate-buffered saline
(PBS) (pH 7.2). After 24 h, fixed tissues were changed to 70% ethanol for 24 h
and then dehydrated and embedded in Paraplast Plus (Oxford Labware, St.
Louis, MO). Several sections (1 to 1.5 cm) from the middle of each uterine horn
were embedded in Tissue-Tek OCT compound (Miles, Oneonta, NY), frozen in
liquid nitrogen vapor, and stored at 80°C. The remaining endometrium was
physically dissected from myometrium, frozen in liquid nitrogen, and stored at
80°C for subsequent RNA extraction.
Study 2. Cyclic ewes (n  20) were checked daily for estrus and then ovari-
ectomized and fitted with indwelling uterine catheters on day 5. Ewes were then
assigned randomly (n  5 per treatment) to receive daily intramuscular (i.m.)
injections of P4 and/or a progesterone receptor and glucorticoid receptor antag-
onist (mifepristone or RU486; Sigma Chemical Company) and intrauterine (i.u.)
infusions of either control (CX) serum proteins and/or recombinant ovine IFNT
as follows: (i) 50 mg P4 (days 5 to 16) and 200 g serum proteins (days 11 to 16)
(P4CX), (ii) P4 and 75 mg RU486 (days 11 to 16) and serum proteins
(P4RUCX), (iii) P4 and IFNT (2  107 antiviral units, days 11 to 16)
(P4IFNT), or (iv) P4 and RU486 and IFNT (P4RUIFNT). Steroids were
administered i.m. daily in corn oil vehicle. Both uterine horns of each ewe
received twice-daily injections of either CX serum proteins (50 g/horn/injec-
tion) or recombinant ovine IFNT (5  106 antiviral units/horn/injection). Re-
combinant ovine IFNT was produced in Pichia pastoris and purified as described
previously (55). Serum proteins were prepared for intrauterine injection as
described previously (44). All ewes were hysterectomized on day 17, and uteri
processed as described for study 1.
RNA isolation. Total cellular RNA was isolated from frozen endometrium
using Trizol (Gibco-BRL, Bethesda, MD) according to the manufacturer’s rec-
ommendations. The quantity and quality of total RNA were determined by
spectrometry and denaturing agarose gel electrophoresis, respectively.
Slot blot hybridization. Total cellular RNA was isolated from frozen endo-
metrium using Trizol reagent (Gibco-BRL, Bethesda, MD) according to the
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manufacturer’s instructions. The quantity and quality of total RNA were deter-
mined by spectrometry and denaturing agarose gel electrophoresis, respectively.
Steady-state levels of BST2 mRNA were assessed by slot blot hybridization using
radiolabeled antisense oBST2A and 18S cRNA probes using methods described
previously (50). Radiolabeled antisense cRNA probes were generated by in vitro
transcription using linearized partial plasmid cDNA templates, RNA poly-
merases, and [	-32P]UTP. Radioactivity associated with slots was quantified
using a Typhoon 8600 MultiImager (Molecular Dynamics, Piscataway, NJ). Data
are expressed as relative units (RU).
Statistical analyses. Data from slot blot hybridization analyses were subjected
to least-squares analysis of variance using the general linear model procedures of
the Statistical Analysis System (SAS Institute Inc., Cary, NC). Slot blot hybrid-
ization data were corrected for differences in sample loading by using the 18S
rRNA data as a covariate. Data were analyzed from study 1 to assess the
oBST2A mRNA levels in cyclic and pregnant ewes and from study 2 for the
effects of treatment (P4CX versus P4IFNT, P4IFNT versus P4R
UIFNT, P4CX versus P4RUCX, and P4RUCX versus P4RUI
FNT), as determined using the LSMEANS/PDIFF option of the Statistical
Analysis System. In all analyses, error terms used in tests of significance were
identified according to the expectation of the mean squares for error. Signif-
icance (P 
 0.05) was determined by probability differences of least-squares
means (LSM). Data are presented as LSM with the overall standard error
(SE).
qRT-PCR. cDNA was synthesized from endometrial total RNA using random
primers (Invitrogen, Carlsbad, CA), oligo(dT) primers, and SuperScript II re-
verse transcriptase (Invitrogen) as described previously (51). Newly synthesized
cDNA was acid-ethanol precipitated, resuspended in 20 l of water, and stored
at20°C for real-time PCR analysis. The PCR analysis of oBST2A, oBST2B, and
ATP1A1 mRNA was performed using an ABI PRISM 7700 (Applied Biosystems,
Foster City, CA) with TaqMan universal PCR master mix, No AmpErase UNG
(Applied Biosystems), as the detector, according to the manufacturer’s recom-
mendations. Briefly, each reaction mixture consisted of 1 l cDNA template, 0.6
l of each primer (10 M), 0.2 l of the TaqMan probe (10 M), and 10 l of
the master mix, with double-distilled H2O (ddH2O) up to 20 l. Primer and
probe sequences were as follows: oBST2A forward primer, 5-GCC GAT ATG
GAG CGA CTA AG-3; oBST2A reverse primer, 5-GCG ATC ACA ACG
AAT AGG AA-3; oBST2A probe, 5-AGA CAG AAT GAG AAC TC-3;
oBST2B forward primer, 5-ACC CTG AAG GAC GCT CTG A-3; oBST2B
reverse primer, 5-GTT CGC CAA CTC TCC CTG A-3; oBST2B probe, 5-
AAG GAT CAG GCA CGA GTG-3; ATP1A1 forward primer, 5-AGA GAG
ATA TGC CAA GAT CGT CG-3; ATP1A1 reverse primer, 5-GGA GCA
CCT TTC ATC ACC AGT A-3; and ATP1A1 probe, 5-CTC CAC CAA CAA
GTA C-3. The PCR cycle parameters were 50°C for 2 min, 95°C for 10 min, and
then 95°C for 15 s and 60°C for 1 min for 40 cycles. Template input was optimized
from serial dilutions of endometrial cDNA for each gene. The final reactions
used 20 ng of cDNA for analysis of oBST2A, oBST2B, and ATP1A1. Data were
analyzed using GeneAmp 5700 SDS software (version 2.2; Applied Biosystems).
The PCR without template was used as a negative control to verify experimental
results. The threshold line was set in the linear region of the plots above the
baseline noise, and threshold cycle (CT) values were determined as the cycle
number at which the threshold line crosses the amplification curve.
Quantification of gene amplification was made following RT-PCR by deter-
mining the CT value for reporter fluorescence within the geometric region of the
semilog plot generated during the PCR. Within this region of the amplification
curve, each difference of one cycle is equivalent to a doubling of the amplified
product of the PCR. The relative quantification of gene expression across days
and treatments was evaluated using the comparative CT method. The CT value
was determined by subtracting the ATP1A1 CT value for each sample from the
target CT value of that sample. Calculation of CT involves using the mean CT
value as an arbitrary calibrator to subtract from all other mean CT values. Fold
changes in the relative mRNA levels for each target gene were then determined
by assuming an amplification efficiency of 2 and by applying the equation 2CT
for each sample.
In situ hybridization analysis. The location of oBST2A or enJSRV env
mRNAs was determined in sections (5 m) of sheep uteri by radioactive in situ
hybridization analysis using methods described previously (50). Archival tissues
collected from cyclic and pregnant cow uteri were also used in this analysis.
Briefly, deparaffinized, rehydrated, and deproteinated uterine tissue sections
were hybridized with radiolabeled antisense or sense cRNA probes generated
from linearized oBST2A cDNA or ovine enJSRV env partial cDNA (DD54) (50)
using in vitro transcription with [	-35S]UTP. After being hybridized, washed, and
digested with RNase A, slides were dipped in NTB-2 liquid photographic emul-
sion (Kodak, Rochester, NY) and exposed at 4°C for 5 days for oBST2A or 3
days for enJSRV env. Slides were developed in Kodak D-19 developer, counter-
stained with Gill’s hematoxylin (Fisher Scientific, Fairlawn, NJ), and then dehy-
drated through a graded series of alcohol to xylene. Coverslips were then affixed
with Permount (Fisher). Images of representative fields were recorded under
bright-field and dark-field illumination using a Nikon Eclipse 1000 photomicro-
scope (Nikon Instruments Inc., Lewisville, TX) fitted with a Nikon DXM1200
digital camera.
Nucleotide sequence accession number. The cDNAs for oBST2A and -2B have
been deposited in GenBank (accession numbers GU376751 and GU376752).
RESULTS
Characterization and cloning of oBST2A and oBST2B. IFNT
is a type I interferon that is secreted by the mononuclear
trophoblast cells of the sheep conceptus and functions as the
pregnancy recognition signal in this species. Production of
IFNT by the conceptus correlates in vivo with maximal expres-
sion of enJSRVs in the uterine endometria of pregnant ewes
(45). Like other type I interferons, IFNT possesses antiviral
activity and can upregulate many genes, including viral restric-
tion factors, such as BST2 (8). The bovine genome contains
two BST2-like genes (referred to here as bBST2A and
bBST2B) located in close proximity on chromosome 7 (13). We
performed RT-PCR on RNA isolated from a sheep choroid
plexus cell line (CPT-Tert) treated or untreated with IFNT by
using oligonucleotide primers designed on the basis of the
bBST2A and bBST2B sequences. Both ovine BST2A and
BST2B (oBST2A and -2B) cDNA were detected in IFNT-
treated CPT-Tert in vitro (Fig. 1A). By sequence analysis,
oBST2A and -2B displayed 75.5% identity at the nucleotide
level and 48.9% at the amino acid level (Fig. 1B). Phylogenetic
analysis of BST2 orthologs showed that oBST2A and bovine
BST2A (bBST2A) cluster on a branch different from that for
oBST2B and bBST2B (Fig. 1C). These data suggest that du-
plication of the BST2 gene occurred before speciation within
the Bovinae and that the two paralogs then evolved indepen-
dently.
enJSRVs/JSRV viral particle release is blocked by oBST2A
and -2B. As shown in Fig. 1, IFNT induces the expression of
oBST2A and -2B in CPT-Tert cells. We next investigated
whether oBST2A and -2B blocked release of enJSRVs and the
related exogenous JSRV viral particles. We used as a repre-
sentative example of the enJSRV proviruses enJSRV-18,
which has an intact genomic organization and is able to release
viral particles in vitro (1). In order to check the restriction
activity of the two ovine BST2 genes, we cotransfected both
human 293T cells and ovine CPT-Tert with expression plas-
mids for JSRV or enJSRV-18 and increasing amounts (0.1 to
1 g) of pCI-oBST2A or pCI-oBST2B (or their respective
HA-tagged versions). We equilibrated the amount of expres-
sion plasmid DNA used for JSRV and enJSRV-18 in order to
express approximately equal levels of Gag (i.e., we used 4 g of
pCMV4JS21 and 1 g of pCMV5enJS18 in a 10-cm petri dish).
Thus, the ratios of the plasmid DNA used to express the
retroviruses studied to oBST2A/B were from 40:1 to 4:1 in
the experimental JSRV series and varied from 10:1 to 1:1 in
the enJSRV-18 series. As shown in Fig. 2, oBST2A was able to
block efficiently both JSRV and enJSRV-18 in 293T cells,
while oBST2B displayed weaker activity (Fig. 2A to D and F to
I). The differences in activity noted between oBST2A and -2B
were present with both the untagged and HA-tagged proteins,
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suggesting that the insertion of the HA epitope did not alter
the function of either protein. We also repeated the experi-
ments above with enJSRV-18 in CPT-Tert cells. Interestingly,
in these cells both oBST2A and -2B were able to interfere with
virus release, although, similarly to what we observed with
human cells, the former displayed higher restriction activity
than the latter. oBST2A migrates in SDS-PAGE/Western blot-
ting as a triplet of bands, similarly to human BST2 (hBST2), a
phenomenon most likely due to N glycosylation of these pro-
teins. Interestingly, oBST2B migrates as a single band and does
not possess any potential N-glycosylation site (Fig. 1C).
As expected, both JSRV and enJSRV-18 were blocked by
hBST2, and viral particle release was rescued only partially by
HIV-1 Vpu (data not shown). The sheep BST2 proteins also
possessed broad antiviral activity, as other orthologs of these
proteins. oBST2A was able to block in a dose-dependent man-
ner HIV-1 Vpu, while oBST2B displayed a less obvious ef-
fect. However, the data for the latter are more difficult to
interpret, considering that a significant decrease in the levels of
HIV-1 Gag in cell lysates was observed with the largest
amounts of oBST2B (Fig. 2E and J). Using the same experi-
mental conditions described above, we performed Western
blotting assays on lysates and supernatants of cells transfected
with expression plasmids for hBST2 and HIV-1 Vpu (Fig.
2K). As expected, hBST2 blocked HIV-1 Vpu in a dose-
dependent manner. We also observed a decrease in the levels
of intracellular HIV-1 Vpu Gag when cells were cotrans-
fected with the highest concentration of hBST2. This may
suggest that within our experimental conditions, higher levels
of BST2 might be cytotoxic. However, a fixed amount of an
expression plasmid for GFP was also used as an additional
control to assess transfection efficiency in all our assays. The
levels of GFP, as revealed by Western blotting, were relatively
consistent, even in the presence of the highest concentrations
of the various BST2 proteins used in our assays. Thus, it is
possible that high levels of oBST2B might facilitate intracellu-
lar Gag degradation, although this point remains to be exper-
imentally assessed.
oBST2A and -2B are expressed in the endometrium of preg-
nant ewes. The data presented so far suggested that IFNT can
upregulate oBST2A and -2B at least in vitro. Here we investi-
gated the effects of IFNT on oBST2A/B in vivo. Figure 3 shows
a schematic representation of the uterus (Fig. 3A) and of the
various early developmental stages of the sheep conceptus.
Note that the blastocyte changes morphology by a rapid tro-
phoblast development (“elongation”) before attaching to the
maternal uterus (Fig. 3B). As mentioned before, IFNT is ex-
pressed by the trophoblast of the sheep conceptus (43, 46, 48),
and consequently, it is detectable only in pregnant ewes.
We carried out in situ hybridization using a BST2 cRNA
antisense probe in order to analyze the ontogeny and location
of BST2 mRNA in the uteri of cyclic and pregnant ewes (Fig.
4). A BST2 sense cRNA probe was used as a negative control
(Fig. 4C and D). BST2 mRNA was essentially undetectable in
FIG. 1. The BST2 gene is duplicated in sheep and is induced by IFNT in vitro. (A) PCR amplification of two distinct ovine BST2 cDNAs by
RT-PCR from total mRNA of sheep choroid plexus (CPT-Tert) cells treated with IFNT. The succinate dehydrogenase (SDHA) cDNA was used
as a control of the RNA quality of each sample. Mk indicates the DNA molecular marker, while M is the mock DNA negative control.
(B) Alignment of the amino acid sequences of the ovine BST2 proteins (oBST2A and -B), gorilla BST2 (gorBST2), mouse BST2 (mBST2), and
human BST2 (hBST2). The arrow indicates a predicted N-glycosylation site that is present in all the above-described sequences, with the exception of
oBST2B. (C) Unrooted phylogenetic tree of the BST2 orthologs constructed by using the neighbor-joining method. Clade support was evaluated based
on 1,000 bootstrap replicates using the same algorithm. Bootstrap values are indicated. Note that the BST2 paralogs in both bBST2 and oBST2 cluster
in different branches of the tree, suggesting that they are conserved and were duplicated before speciation. Each ortholog is differentiated using a letter
in front of “BST2” as follows: bBST2, bovine (Bos taurus); oBST2, ovine (Ovis aries); cpzBST2, chimpanzee (Pan troglodytes troglodytes); hBST2, human
(Homo sapiens); macBST2, macaque (Macaca mulatta); chlBST2, vervet monkey (Chlorocebus aethiops); gorBST2 (Gorilla gorilla); rBST2, rat (Rattus
norvegicus); mBST2, mouse (Mus musculus); canBST2, dog (Canis familiaris); swBST2, pig (Sus scrofa domesticus).
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endometria from cyclic ewes between days 10 and 16 (Fig. 4A,
B, E, F, I, and J and data not shown). Similarly, BST2 mRNA
was not detected in the endometria of days 10 and 12 pregnant
ewes (Fig. 4G and H and data not shown) but was detected
thereafter (days 14 to 20) at increasing levels, specifically in the
stroma of the endometrium but not in the luminal epithelia,
superficial glandular epithelia, or middle or deep glandular
epithelia (Fig. 4L, N, P, R, and T). Moreover, BST2 mRNA
was not detected in the trophoblast of the conceptuses present
in uteri from days 18 and 20 of pregnancy (Fig. 4Q and R and
data not shown). Note that the probe used for in situ hybrid-
ization analyses would detect both oBST2A and oBST2B
mRNAs. Essentially, the same results were obtained by in situ
hybridization in tissue sections obtained from cow uteri. BST2
expression was detected exclusively in the stroma of the endo-
metrium of cows from day 16 of pregnancy and was not de-
tected in cyclic cows (Fig. 5 and data not shown).
Slot blot hybridization analyses confirmed that steady-state
FIG. 2. oBST2A and -2B block viral particle release by JSRV, enJSRV-18, and HIV-1 Vpu. Western blotting of concentrated viral particles
from supernatants (Virus) and cellular extracts (lysates) of 293T or CPT-Tert cells cotransfected with expression plasmids for viruses and BST2
proteins was as indicated in each panel. Cells were transfected in a 10-cm-diameter petri dish with a fixed amount of expression plasmids for either
JSRV (D and I), enJSRV-18 (A to C and F to H), or HIV-1 Vpu (E, J, and K), and increasing amounts of expression plasmids for oBST2A,
oBST2B (either the untagged or HA-tagged versions), or hBST2 (the HA-tagged version). Blots were incubated with the appropriate antisera, as
indicated in each panel. Viral particle release was quantified, and values represent arbitrary units relative to the values of each virus transfected
in the absence of BST2 (which was assigned a value of 100). Representative experiments are shown and were repeated at least three times
independently.
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levels of oBST2A/B mRNA in the endometria of pregnant
ewes were considerably higher than those in cyclic (i.e., non-
pregnant) ewes (Fig. 6). In cyclic ewes, oBST2A mRNA levels
were very low and did not change during the cycle (P  0.10).
In contrast, endometrial oBST2A mRNA levels increased sub-
stantially in pregnant ewes after day 12, increased 10-fold on
day 14, and remained high to day 20 (P 
 0.01) (Fig. 6A). In
these experiments we used the same probe utilized in the in
situ hybridization studies described above that do not abso-
lutely discriminate between oBST2A and -2B. By using specific
primers for oBST2A or -2B, we were able to detect a 7-fold
increase in the levels of oBST2A RNA in the endometrium of
day 16 pregnant ewes compared to those in the same tissue
collected at day 16 in cyclic ewes (Fig. 6B). A similar pattern
was observed for oBST2B, although the increase in the RNA
levels in pregnant ewes compared to cyclic ewes was more
modest (3.8-fold; Fig. 6B). Thus, the data obtained indicate
that oBST2A and -2B are expressed predominantly in the
stroma of the endometrium of early pregnant ewes after day 12
of pregnancy. Of note, enJSRV expression is limited to the
luminal and glandular epithelia of the ovine uterus and is
undetectable in the stroma or myometrium (36, 37, 50) (Fig.
7M to V).
oBST2A expression is induced by IFNT in vivo. The tempo-
ral increase of oBST2A/B in the endometrium of pregnant
sheep beginning on day 12 of pregnancy is correlated directly
to the amount of IFNT secreted by the trophectoderm of the
rapidly elongating conceptus (Fig. 3B) (49). As reviewed by
Spencer et al. (49), many of the genes expressed in the endo-
metrium of early pregnant ewes are regulated by progesterone
(P4) produced by the corpus luteum and IFNT from the con-
ceptus trophectoderm. Therefore, we used an in vivo hormone
replacement model (Fig. 7A) that mimics the effects of P4 and
IFNT on endometrial expression of hormone receptors and
IFNT-stimulated genes during early pregnancy in the ewe (4).
Briefly, cyclic ewes were ovariectomized and fitted with intra-
uterine (i.u.) catheters on day 5, treated with exogenous P4
from days 6 to 17, and given intrauterine infusions of serum
proteins as a control (CX) or IFNT from days 11 to 17. The
effect of progesterone was assessed by blocking specifically its
action through its nuclear receptor using a progesterone re-
ceptor antagonist (RU486). As shown in Fig. 7B, treatment of
ewes with the RU486 progesterone receptor antagonist did not
affect (P  0.10, P4CX versus P4RUCX) endometrial
BST2 mRNA abundance. For ewes receiving P4 alone, intra-
uterine infusions of recombinant ovine IFNT increased (P 

0.001) steady-state levels of BST2 mRNA in the endometria
(P 
 0.001, P4CX versus P4IFNT) (Fig. 7B). Similarly, for
ewes receiving P4RU treatment, intrauterine infusions of
recombinant ovine IFNT increased BST2 mRNA in the endo-
metrium (P 
 0.001, P4RUCX versus P4RUIFNT). In
situ hybridization analyses verified that IFNT increased BST2
mRNA abundance in the endometrium (Fig. 7C to L). Simi-
larly to that in pregnant ewes, oBST2A mRNA was detected
only in the stroma of the endometria from ewes receiving P4
and IFNT (Fig. 7E and F), whereas oBST2A mRNA was
detected both in the endometrial stroma and in the luminal
epithelium of the uteri of ewes receiving P4, RU486, and IFNT
(Fig. 7I and J). Collectively, these results support the idea that
IFNT from the elongating conceptus induces expression of
oBST2A/B specifically in the stromal cells of the endometrium.
In contrast, in situ hybridization analyses detected enJSRVs
mRNA only in the endometrial luminal and glandular epithe-
lium but not in the stroma or myometrium (Fig. 7M and V).
Moreover, the relative abundance of enJSRVs RNA in the
endometrial epithelia was unaffected by treatment.
DISCUSSION
In order to further understand the interaction between en-
JSRVs and their hosts, we investigated the interplay between
the ovine BST2 genes and the endogenous betaretroviruses of
sheep (enJSRVs). The sheep genome harbors several copies of
enJSRV proviruses that are biologically active, abundantly ex-
pressed in the reproductive tract of the ewe, and absolutely
FIG. 3. Schematic diagram of the sheep endometrium and early
ovine embryo development. (A) Cross-section of the ovine uterus. The
main cellular compartments important for this study are the luminal
and glandular epithelia of the endometrium and the stroma. (B) Early
embryo development. The fertilized oocyte develops into a multicel-
lular morula at day 4 of pregnancy and then into a hatched spherical
blastocyst by days 7 to 8 that consists of an inner cellular mass sur-
rounded by a layer of mononuclear trophoblast cells. Between days 12
and 16, the spherical blastocyst elongates to form a filamentous con-
ceptus that secretes the pregnancy recognition signal, IFNT, and be-
gins the process of implantation.
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required for successful pregnancy in this animal species (3, 11,
12, 14, 35, 38, 57). enJSRVs are highly related to the exogenous
and oncogenic JSRV, the causative agent of ovine pulmonary
adenocarcinoma, a naturally occurring lung adenocarcinoma
of sheep (14, 26, 35). Interestingly, the sheep (and cow) con-
ceptus secretes IFNT, a type I interferon, which functions as a
pregnancy recognition signal in this animal species, although it
maintains potent antiviral properties. Thus, the sheep repre-
sents a unique model system to investigate the coevolution of
endogenous and exogenous retroviruses with host antiviral de-
fenses.
The present study found that the BST2 gene is duplicated in
sheep as in cattle. Phylogenetic analysis supports the idea that
this duplication occurred approximately 25 million years ago
(MYA) before speciation in the Bovinae subfamily within the
ruminants (19). Thus, duplication of BST2 predates the initial
integration of enJSRVs in the host genome that we estimated
occurred between 5 and 7 MYA (1). Both oBST2A and
oBST2B blocked viral particle release of enJSRV-18 and the
exogenous JSRV. As expected, the antiretroviral activity of
these proteins is not specifically targeted to the sheep betaret-
roviruses, but they have a broader spectrum, considering that
FIG. 4. Expression of oBST2 in the endometrium of cyclic and pregnant ewes. In situ hybridization analyses of BST2 mRNA in uteri of cyclic
and pregnant ewes. Cross-sections of the uterine wall from cyclic (10C, 12C, 14C; A, B, E, F, I, and J) and pregnant (12P, 14P, 16P, 18P, and 20P;
G, H, K, L, O, P, Q, R, S, and T) ewes were hybridized with radiolabeled antisense ovine BST2 cRNA probe. Numbers (10C, 12C, 12P, etc.)
indicate the day of the cycle (C) or pregnancy (P) of the ewes used in these experiments. (C and D) A sense ovine BST2 cRNA probe was used
as a negative control. Images of representative fields are shown both in bright-field (panels A, C, E, G, I, K, M, O, Q, and S) and dark-field
illumination (panels B, D, F, H, J, L, N, P, R, and T). BST2 mRNA was observed with endometrial stroma of sheep beginning at day 14 of
pregnancy (panels L, N, P, R, and T) but not in the luminal epithelia (LE), superficial glandular epithelia (sGE), middle or deep glandular epithelia
(GE) of the endometrium, or in the conceptus trophectoderm (Tr). A superimposed red line is shown in panels K to T in order to facilitate the
visualization of the LE and GE of the uterus in the sections shown under dark-field illumination. Car, caruncle; S, stroma; Tr, trophectoderm.
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HIV-1 Vpu can also be blocked by oBST2A/B. These data
support the idea that oBST2A has more antiretroviral activity
than oBST2B. We speculate that the difference in antiretrovi-
ral activities between oBST2A and -2B is due to the proteins
per se and not to JSRV/enJSRV-18 (viral) factors. Interestingly
oBST2B does not possess any predicted N-glycosylation site.
We were also unable to identify any GPI anchor signals in the
C terminus of this protein. The use of oBST2B mutants and
more mechanistic studies will be necessary to determine the
molecular basis at the origin of the poor antiviral activity of this
protein. Indeed, it is possible that oBST2B may have evolved
to serve other functions besides viral restriction.
The two oBST2 proteins displayed stronger restriction ac-
tivity in sheep cells than in human 293T cells. The difference in
these two cell types could be due to ovine-specific cofactors
important for oBST2 restriction. As mentioned above,
oBST2A inhibits equally well HIV-1 Vpu, JSRV, and en-
JSRV-18 viral particle release. These data support the argu-
ment that JSRV/enJSRV-18 do not possess a viral protein
counteracting oBST2 restriction.
In the present study, we found that oBST2A and oBST2B
genes were induced by IFNT both in vitro and, importantly, in
vivo. Pregnant sheep showed much higher levels of oBST2A/B
expression in their endometria than cyclic (i.e., nonpregnant)
sheep. The levels of oBST2A/B were correlated to the amount
of IFNT produced by the mononuclear trophoblast cells of the
elongating conceptus. By using an in vivo hormone replace-
ment model (4), we showed that IFNT induces expression of
oBST2A/B in the endometrium of the sheep uterus. Indeed,
oBST2A is expressed at higher levels than oBST2B. Using a
probe that would detect both BST2 mRNAs, in situ hybridiza-
tion analyses revealed that expression of BST2 was restricted
to the stromal cells of the endometrium of the ewe. Thus,
enJSRVs and BST2 are expressed in different cellular com-
partments of the same organ. enJSRVs are expressed in the
luminal and glandular epithelium of the uterus, while oBST2A
and oBST2B are expressed in the stroma. As mentioned above,
duplication of the BST2 gene predates the initial integration of
enJSRVs of several million years. Therefore, oBST2A/B could
have been one of the driving forces during evolution that
shaped the tropism of enJSRV-related exogenous viruses
within specific areas of the reproductive tract (i.e., where the
BST2 proteins are not expressed). Subsequently, germ line
infections by those exogenous viruses led to the selection of
enJSRVs present today within the sheep genome. Alterna-
tively, it is possible that sheep have evolved mechanisms to
repress BST2 expression in the luminal epithelial cells in order
to create a favorable environment for the function of these
endogenous retroviruses in host reproductive biology (10–12,
FIG. 5. Expression of oBST2 in the endometrium of pregnant
cows. In situ hybridization analyses of BST2 mRNA in uteri of preg-
nant cows. Cross-sections of the uterine wall from pregnant cows (13P,
16P, 19P; A to F) were hybridized with a radiolabeled antisense ovine
BST2 cRNA probe. A sense ovine BST2 cRNA probe was used as a
negative control (G and H). Numbers (13P, 16P, etc.) indicate the day
of the pregnancy of the cows used in these experiments. Images of
representative fields are shown both in bright-field (A, C, E, and G)
and dark-field illumination (B, D, F, and H). BST2 mRNA was ob-
served in endometrial stroma (S) of cows beginning at day 16 of
pregnancy but not in the luminal epithelia (LE) or glandular epithelia
(GE) of the endometrium.
FIG. 6. Relative quantification of BST2A and -2B RNA in cyclic and pregnant ewes. (A) Steady-state levels of BST2A/B mRNAs in endometria
from cyclic and early pregnant ewes were determined by slot blot hybridization analysis. In cyclic ewes, BST2 mRNA was low between days 3 and
16. In contrast, BST2 mRNA increased (P 
 0.01) in pregnant ewes between days 12 and 14 and remained maximal between days 14 and 20. Data
are expressed as LSM relative units (RU) with standard errors (SE). (B) Relative levels of BST2A and BST2B mRNA in the endometria of day
16 cyclic and pregnant ewes. The relative mRNA abundance was calculated from the quantitative RT-PCR analysis as described in Materials and
Methods.
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45, 57). However, we believe that the latter scenario is unlikely
because cows, which do not harbor enJSRVs in their genome
(1), have a pattern of BST2 expression identical to that of
sheep.
In the ovine uterus, the luminal and superficial glandular
epithelial cells express a potent transcriptional repressor, IFN
regulatory factor 2 (IRF2), that inhibits the activation of many
genes induced by IFNT during pregnancy, including many an-
FIG. 7. IFNT induces expression of oBST2 in vivo. Effects of progesterone and IFNT on BST2 mRNA in the ovine uterus. (A) Experimental design.
See Materials and Methods for complete description. CX, control serum proteins; P4, progesterone; IFNT, recombinant ovine tau interferon; RU,
RU486 antiprogestin. (B) Steady-state levels of oBST2 mRNA in endometria as determined by slot blot hybridization analysis. Intrauterine infusion of
IFNT increased oBST2 mRNA in the endometrium of P4-treated ewes (P4CX versus P4IFNT, P 
 0.001) as well as in ewes receiving the RU486
antiprogestin (P4IFNT versus P4RUIFNT, P
 0.001). (C to L) In situ hybridization analysis of oBST2 mRNA expression similar to that described
in the legends for Fig. 4 and 5. IFNT increased BST2 mRNA in a cell-type-specific manner in P4-treated ewes, consistent with increased expression in
uteri from day 14, 16, and 18 pregnant ewes. Intrauterine injections of IFNT increased BST2 mRNA in endometrial stroma but not in LE, GE, or
myometrium. A red line has been superimposed to facilitate the visualization of the luminal and glandular epithelia of the uterine stroma. (M to V) In
situ hybridization analysis of enJSRV env RNA expression. The enJSRV env RNA was specifically and abundantly present in the endometrial LE and
GE but not in the stroma or myometrium.
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tiviral proteins and classical IFN-stimulated genes (5, 9, 16).
Thus, the luminal epithelial cells could have represented a
window of opportunity for the replication of enJSRVs. Curi-
ously, we detected oBST2A expression also in the uterine
epithelium in sheep treated with progesterone, IFNT, and the
progesterone antagonist RU486. It is possible that in the pres-
ence of RU486, IRF2 is not expressed or is not active in the
luminal epithelium cells of the uterus. Indeed, progesterone
normally acts on the stroma cells (which are progesterone
receptor positive) and stimulates growth factors, such as fibro-
blast growth factor 10 (FGF10). In turn, FGF10 acts on the
luminal epithelium via its receptor in order to activate signal-
ing pathways that are known to modify transcription factors
like IRFs (5, 9). Thus, treatment with RU486 likely deregulates
the normal homeostasis of the sheep endometrium and could
explain the upregulation of BST2 in the luminal epithelium of
ewes infused with IFNT receiving the RU486 antiprogestin.
As mentioned above, the exogenous and pathogenic JSRV is
also blocked as efficiently as enJSRV-18 by both oBST2A and
-2B. One could have expected that the exogenous JSRV was
able to overcome the block induced by BST2. Thus, replication
in cellular compartments devoided of BST2 expression may be
one of the strategies used by retroviruses to avoid the antiviral
response of the host.
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